Shire Blocks Actavis' Generic Lialda Until 2020
A Florida federal judge on Thursday blocked Actavis Inc.'s bid to launch a generic version of Shire PLC's inflammatory bowel disease treatment Lialda, ruling that Shire's patent for the drug was...To view the full article, register now.
Already a subscriber? Click here to view full article